Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Xiamen Yan Palace Bird's Nest Industry Co., Ltd. (1497.HK)
Xiamen, FU, CN
Xiamen Yan Palace Bioengineering Co., Ltd. engages in the manufacture and distribution of food supplements. It offers tea based beverages and bird nest food products. The company provides its products in Bowl Yan Brand, Dried Yan Brand & other series. Xiamen Yan Palace Bioengineering was founded on October 31, 2014 and is headquartered in Xiamen, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.45% | +10.08% | +18.47% | +14.40% | -0.14% | +21.14% | +9.22% | -27.94% | -27.94% | -27.94% | -27.94% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Food Distribution: +7.7%-2.4% Q4'25: +11.0% (vs Q4'23)
-
EPS growth Food Distribution: +4.1%+20.6% ★ Q4'25: +8.7% (vs Q4'23)
-
FCF margin FCF growth · Food Distribution: +15.4%+17.3% ★ Q4'25: +18.6% (vs Q4'23)
-
EBIT margin Food Distribution: +3.6%+14.5% ★ Q4'25: +17.4% (vs Q4'23)
-
ROIC Food Distribution: +6.5%+69.0% ★ Q4'25: +161.2% (vs Q4'23)
-
Share dilution Food Distribution: +0.0%-1.2% ★ Q4'25: +6.4% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Food Distribution: 0.80×0.35× ★ Q4'25: 0.15× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|
| Revenue |
1.96B
est: 2.17B (-9.3%)
|
2.05B
est: 2.23B (-8.0%)
|
2.00B
est: 2.16B (-7.5%)
|
2.23B
2.23B – 2.23B
+2.9% YoY
|
2.41B
2.41B – 2.41B
+8.3% YoY
|
| EBITDA |
317.06M
est: 292.14M (+8.5%)
|
224.85M
est: 379.65M (-40.8%)
|
318.39M
est: 368.66M (-13.6%)
|
379.20M
379.20M – 379.20M
+2.9% YoY
|
410.86M
410.86M – 410.86M
+8.3% YoY
|
| EBIT |
276.25M
est: 268.77M (+2.8%)
|
206.05M
est: 332.71M (-38.1%)
|
290.24M
est: 323.08M (-10.2%)
|
332.31M
332.31M – 332.31M
+2.9% YoY
|
360.06M
360.06M – 360.06M
+8.3% YoY
|
| Net Income |
201.22M
est: 213.02M (-5.5%)
|
156.30M
est: 186.62M (-16.2%)
|
188.56M
est: 168.15M (+12.1%)
|
193.67M
193.67M – 193.67M
+15.2% YoY
|
198.40M
198.40M – 198.40M
+2.4% YoY
|
| SGA |
722.79M
est: 637.89M (+13.3%)
|
810.12M
est: 738.21M (+9.7%)
|
808.01M
est: 716.83M (+12.7%)
|
737.33M
737.33M – 737.33M
+2.9% YoY
|
798.89M
798.89M – 798.89M
+8.3% YoY
|
| EPS |
0.45
est: 0.46 (-2.6%)
|
0.34
est: 0.41 (-17.0%)
|
0.41
est: 0.37 (+11.1%)
|
0.43
0.43 – 0.43
+15.2% YoY
|
0.44
0.44 – 0.44
+2.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-28 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-22 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-14 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-13 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 4/5 | 2/5 |
| 2026-05-12 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 4/5 | 2/5 |
| 2026-05-11 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 4/5 | 2/5 |
| 2026-05-08 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 4/5 | 2/5 |
| 2026-05-07 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 4/5 | 2/5 |
| 2026-05-06 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 4/5 | 2/5 |
| 2026-05-05 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 4/5 | 2/5 |
| 2026-05-04 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 4/5 | 2/5 |
| 2026-04-30 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 4/5 | 2/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-17 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-16 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-15 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Youquan Li | GM & Executive Director | 4M | male |
| Jian Huang | Executive Chairman of the Board of Directors | 3M | male |
| Wenbin Zheng | Executive Vice Chairman of the Board | 1M | male |
| Danyan Huang | Deputy GM & Executive Director | 1M | female |
| Qunyan Fan | Deputy General Manager | — | male |
| Ting Xiong | Joint Company Secretary | — | female |
| Zhigao Chen | Deputy GM & CFO | — | male |
| Huizhen Weng | Deputy General Manager | — | female |
| Kwan Wai Leung | Joint Company Secretary | — | female |
| Liangjie Li | Deputy General Manager | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 1497.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
